Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NA-PHER2: Palbociclib in Neoadjuvant Breast Cancer
NCT02530424Phase 2Completed
- Sponsor
- Michelangelo Foundation
- Start
- May 2015
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in breast cancer, sponsored by Michelangelo Foundation. Started May 2015; status: completed.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02530424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02530424.